PARP Inhibitors - Globe Thesis

Keyword [PARP Inhibitors] Result: 1 - 20 \| Page: 1 of 2
1.	Research On Computer-Aided Drug Design, Synthesis And Initial Activity Evaluation Of γ-Secretase Inhibitors With Neuroprotective Effect
2.	The Design, Synthesis And Neuroprotective Effect Of PARP Inhibitors
3.	WZ-8, A New PARP Inhibitor, Exhibits Potent Antitumor Effects In Vitro And In Vivo
4.	Screening And Activity Evaluation Of PARP Inhibitors
5.	Phosphoglycerate Mutase 1 Is Required For Homologous Recombination Repair Via Sustaining The Stability Of CtIP
6.	Discovery And Development Of 2,3-Difluoro-5-(Phthalazinone-4-Methyl)-Benzamides As PARP Inhibitors And Second-Generation FP-2&PfDHFE Dual Inhibitors As Antimalarial Drugs
7.	Screening And Evaluation Of Anti-tumor Activity Of PARP Inhibitors
8.	Poly (ADP-ribose) Polymerase (PARP) Inhibitors For The Treatment Of Recurrent Epithelial Ovarian Cancer:a Meta-analysis
9.	Meta Analysis Of The Efficacy And Safety Of Poly(ADP-ribose) Polymerase (PARP) Inhibitors In The Treatment Of Ovarian Cancer
10.	Studies On Predictive Biomarkers Of PARP Inhibitors And On Characteristics And Machanisms Of Tumor Resistance To Them
11.	The Radiosensitization Effect Of PARP Inhibitors On Hypoxic Esophageal Squamous Cell Carcinoma Cells
12.	Studies On Antitumor And Resistance Mechanisms Of PARP Inhibitors
13.	Metformin Regulates Epithelial-mesenchymal Transition And PD-L1 To Reverse PARP Inhibitors Resistance In Triple-negative Breast Cancer
14.	The Sensitizing Effect Of Mir-509-3 On PARP Inhibitors In High-grade Serous Ovarian Cancer Based On PDX Models
15.	The Study On The Synergistic Anti-cancer Effects Of ROS Elevating Drugs And PARP Inhibitors
16.	Targetirng The ?H2AX-MDC1 Axis For Cancer Therapeutics
17.	Meta-analysis Of The Efficacy And Safety Of PARP Inhibitors In The Maintenance Of Recurrent Ovarian Cancer
18.	Studies On The Expression Of Key Proteins Of Homologous Recombination Repair And The Abnormal Mutation Of The Related Genes In Epithelial Ovarian Cancer
19.	Pharmacogenomic Analysis Of Sensitivity And Drug Resistance To PARP Inhibitors(Olaparib)
20.	Efficacies And Toxicities Associated With Poly ADP-Ribose Polymerase(PARP)Inhibitors In The Treatment Of Advanced Breast Cancer:A Meta-Analysis
<<First <Prev Next> Last>> Jump to